Skip to content

Clinical trials

Burkitt Lymphoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20131
20151
20161
20201
20222
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting6
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center3
AstraZeneca2
Seoul National University Hospital2
Cothera Bioscience, Inc1
Gachon University Gil Medical Center1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Pfizer1
Sung-Soo Park1
Xencor, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma14
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Non-Hodgkin6
Lymphoma, Follicular5
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Mantle-Cell4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Recurrence4

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.